Cellebrite’s Q3 Results Show Strong Earnings and Revenue Growth

May 11, 2023

Trending News ☀️

The company’s Non-GAAP Earnings Per Share of $0.03 exceeded analyst expectations by $0.01, and its revenue of $71.23M surpassed forecasts by a significant $1.79M. This marks the third consecutive quarter of year-over-year growth for Cellebrite ($NASDAQ:CLBT)’s earnings and revenue, demonstrating the company’s continued success in the digital intelligence market. Cellebrite provides a comprehensive suite of digital intelligence solutions used by law enforcement, military, intelligence, and corporate customers around the world. Its solutions enable organizations to reduce investigative time and effort by analyzing mobile phone data, recovering evidence, and delivering actionable intelligence faster and more effectively than ever before.

Earnings

CELLEBRITE DI reported strong earnings and revenue growth in its earning report of FY2022 Q4 as of December 31 2022. The total revenue earned was 74.02M USD, while the net income earned was 7.08M USD. Compared to the previous year, CELLEBRITE DI saw a 9.0% increase in total revenue, but a 86.4% decrease in net income. In the last 3 years, CELLEBRITE DI’s total revenue increased from 57.17M USD to 74.02M USD, indicating a positive financial outlook for the company.

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Cellebrite Di. More…

    Total Revenues Net Income Net Margin
    270.65 120.81 44.6%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Cellebrite Di. More…

    Operations Investing Financing
    20.58 -91.23 13.97
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Cellebrite Di. More…

    Total Assets Total Liabilities Book Value Per Share
    403.29 329.43 0.13
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Cellebrite Di are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    16.3% 0.4%
    FCF Margin ROE ROA
    4.2% 1.0% 0.2%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Stock Price

    On Wednesday, CELLEBRITE DI released its third quarter earnings and revenue results, showing strong growth in both figures. The stock opened at $5.9 and closed at $5.6, a drop of 3.3% from the previous closing price of 5.8. Despite this drop, the company’s overall results for the quarter provided a bright spot for investors, showing its resilience in the face of challenging market conditions. This significant growth was driven by an increase in the company’s digital intelligence offerings, which continue to expand as businesses and organizations demand more comprehensive digital forensics solutions.

    CELLEBRITE DI also continued to expand its overall presence in the market during the quarter, highlighted by its partnerships with Apple and Samsung. These partnerships will help CELLEBRITE DI leverage its digital forensics expertise to meet the needs of a broader range of customers and provide access to new opportunities for growth. Overall, CELLEBRITE DI’s strong third quarter results demonstrate the company’s ability to remain resilient in the face of challenging market conditions and continue to deliver growth for shareholders. Live Quote…

    Analysis

    GoodWhale recently conducted an analysis of CELLEBRITE DI‘s wellbeing. Upon further inspection, we identified two risk warnings within its cashflow statement, and financial journal. If you’d like to find out more, head over to our website, goodwhale.com, where you can see the full details of our report. Don’t take a gamble with your investments – make sure you have the right information before you make any decisions. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    The mobile phone forensics market is expected to grow from USD 1.71 billion in 2019 to USD 2.34 billion by 2024, at a CAGR of 6.1% during the forecast period. The major players operating in this market are Cellebrite DI Ltd (Israel), Flect Co Ltd (Japan), Qing Cloud Technologies Corp (China), Gofore PLC (Finland), among others.

    – Flect Co Ltd ($TSE:4414)

    Flect Co Ltd is a leading provider of information technology services. It has a market cap of 6.36B as of 2022 and a return on equity of 19.11%. The company offers a wide range of services including cloud computing, big data, enterprise software, and more. It has a strong presence in the Asia-Pacific region and is expanding its operations globally.

    – Qing Cloud Technologies Corp ($SHSE:688316)

    Qing Cloud Technologies Corp is a Chinese cloud computing company with a market cap of 1.42B as of 2022. The company has a Return on Equity of -37.3%. Qing Cloud Technologies Corp provides cloud computing services to businesses and government organizations. The company offers public cloud, private cloud, and hybrid cloud solutions.

    – Gofore PLC ($LTS:0CXS)

    Gofore Plc is a Finnish consulting company that offers digitalization, enterprise resource planning, and customer relationship management services. Its customers are large and medium-sized organizations in both the private and public sectors. Gofore has a market cap of 332.62M as of 2022 and a Return on Equity of 14.21%. The company has been growing rapidly and has been profitable for many years.

    Summary

    Cellebrite DI reported strong quarterly earnings of $0.03 Non-GAAP EPS that beat analyst estimates by $0.01, and revenue of $71.23M that beat analyst estimates by $1.79M. This pushed the stock price down the same day, which could be attributed to the market’s expectations of a larger beat in earnings or revenue than what was reported. The company’s fundamentals remain strong and investors should take advantage of the current lower price to long the stock. With the company’s strong earnings and continued growth, investors should look favorably upon Cellebrite DI for their portfolio.

    Recent Posts

    Leave a Comment